Agenda - Workshop on Recombinant Protein-based COVID-19 Vaccines
April 27th, 2023, 9AM – 1 PM EDT
Recombinant Protein-Based COVID-19 Vaccines Workshop Event Page
| Time | Speaker | Subject |
|---|---|---|
| 9:00 AM – 9:05 AM | Peter Marks, CBER OD, FDA |
Welcome Remarks |
| 9:05 AM – 9:20 AM | Robert Johnson, BARDA |
Pandemic preparedness, target product profile, timelines, and the need for continued investment |
| 9:20 AM – 9:35 AM | Natalie Thornburg, CDC |
Epidemiology, disease burden, continued need for COVID-19 vaccines |
| 9:35 AM – 10:00 AM | John Beigel, NIH |
Features of novel vaccines, need for next generation vaccines |
| 10:00 AM – 10:20 AM | Presentation – Novavax, Inc. Filip Dubosky, Rick Crowley |
Recombinant COVID-19 vaccines |
| 10:20 AM – 10:40 AM |
Presentation – Sanofi |
Recombinant COVID-19 vaccines |
| 10:40 AM – 11:00 AM | Presentation – SK bioscience Harry Kleanthous |
Recombinant COVID-19 vaccines |
| 11:00 AM – 11:20 PM | Presentation – Dyadic Mark Emalfarb |
Recombinant COVID-19 vaccines |
| 11:20 AM – 11:40 AM | Presentation – Biological E, Limited Vikram Parakdar |
Recombinant COVID-19 vaccines |
| 11:40 AM – 12:00 PM | Presentation – Intravacc Dinja Oosterhoff |
Recombinant COVID-19 vaccines |
| 12:00 PM – 12:10 PM | Break |
Break |
| 12:10 PM – 12:55 PM | Frank Arnold, BARDA Jerry Weir, FDA Joel Straus, BIO Dave Robinson, BMGF Adam Hacker, CEPI |
Panel Discussion |
| 12:55 PM – 1:00 PM | David Kaslow |
Closing |